DAILY / MAY 3, 2014, VOL. 4, NO. 18   Send Feedback l View Online
Psychiatric News Update
The Voice of the American Psychiatric Association and the Psychiatric Community
 CURRENT ISSUE  ::  PN ARCHIVES  ::  NEWS ALERT  ::  CONTACT US  twitter facebook linkedin
2014 APA's Annual Meeting Special Edition

Jeffrey Borenstein, M.D.APA’s 2014 annual meeting began in New York today. From now till May 7, you’ll be receiving daily highlights of the meeting through news articles and multimedia interviews. Whether you are here in New York or at home, these reports will convey the excitement and outstanding scientific program being presented at this year’s meeting. Jeffrey Borenstein, M.D., editor in chief of Psychiatric News, gives you a BRIEF INTRODUCTION...

Jeffrey Lieberman, M.DLieberman Looks Back on Landmark Year in Psychiatry
In this video, Jeffrey Borenstein, M.D., interviews outgoing president Jeffrey Lieberman, M.D., as he recounts the highlights of his APA presidential year: the publication and record sales of DSM-5; the appointment of a new CEO and medical director, Saul Levin, M.D., M.P.A.; APA’s engagement in health care reform and leadership in federal legislative and policy initiatives; and input on implementation of the parity law through the final rule. >>watch video

Saul Levin, M.D., M.P.A.Levin Shaping APA to Meet Evolving Needs of Members
In this video, Jeffrey Borenstein, M.D., interviews APA CEO and Medical Director Saul Levin, M.D., M.P.A. Levin, an APA member since 1986, is making changes at APA that will help members put themselves in a strong position to meet psychiatry’s future and provide outstanding care. “This is your professional home,” he says. >>watch video

Thomas Insel, M.D.Insel Outlines the Psychiatry of the Future Treating Disorders of Neural Circuitry
The diagnosis and treatment of mental illness is haunted by four “inconvenient truths.” That’s what NIMH Director Thomas Insel, M.D., told APA members today in his annual meeting lecture “From Psychiatry to Clinical Neuroscience.” Those inconvenient truths are these….
>>read more

Kimberly Yonkers, M.D.To Treat or Not to Treat During Pregnancy: That Is the Question
The association of major depressive disorder (MDD) with preterm birth or low birth weight does not appear to be strong; at the same time, antidepressant medication use is a distinct risk factor but the overall effect is not large, reducing duration of gestation by only about 3-5 days.... >>read more

Jesse H. Wright, M.D.Cognitive-Behavioral Therapy for Severe Mental Illness
With growing evidence for the usefulness of cognitive-behavioral therapy (CBT) for severe conditions such as schizophrenia, bipolar disorder, and medication-refractory depression, there has been increased interest in learning CBT methods that can be combined with pharmacotherapy to manage difficult-to-treat patients.... >>read more

Elspeth Cameron Ritchie, M.D.The New Buzz in PTSD Care:
How Complementary and Alternative Medicine Helps Patients
When it comes to effectively treating posttraumatic stress disorder (PTSD), clinicians and researchers alike agree that more effective therapies are sorely needed, especially in the aftermath of combat.... >>read more

Lori Raney, M.D.Risk Management and Liability Considerations in Integrated Care Setting
An issue that often concerns psychiatrists as they gear up to practice in integrated care settings is the liability that may be incurred while doing “informal” consultations and working with other providers in varying models of “split treatment.” .... >>read more

Nada Stotland, M.D.The Myth of Abortion Trauma
Psychiatrists who treat women see patients who have had, who are contemplating, or who will have abortions; one-third of the women in the United States have an induced abortion at some time in their lives.... >>read more

John Gunderson, M.D.What Is ‘Good Psychiatric Management’ for Borderline Personality Disorder?
Most psychiatrists dislike and avoid treating patients with borderline personality disorder (BPD), according to John Gunderson, M.D. This is truly unfortunate, he said, because it is based on misinformation about the disorder. It is against this backdrop that Gunderson introduced a new therapy for BPD called “Good Psychiatric Management” (GPM).... >>read more

Remington Nevin, M.D., M.P.H.The Mefloquine Toxidrome: A Common Confounder of Mental Illness Among Returning Veterans?
Clinicians evaluating returning U.S. military veterans with certain psychiatric complaints need to be aware of the potentially confounding role of antimalarial neurotoxicity, said Remington Nevin, M.D., M.P.H. Nevin’s work contributed to the FDA’s issuing an updated boxed warning for mefloquine in late July 2013.... >>read more

Anne Bodmer Lutz, M.D.Solution-Focused Approach to Care Empowers Patients
As physicians shift care from a disease-centered to a patient-centered clinical method, there is a need for a compatible counseling paradigm. Solution-focused therapy is an evidenced-based approach highly congruent with patient-centered care.... >>read more

Arshya Vahabzadeh M.D.Residents’ Journal
Shines in the Big Apple
With APA’s annual meeting filled with so many exciting events for psychiatry trainees, we were pleasantly surprised by the outstanding turnout for the American Journal of Psychiatry Residents’ Journal “How to be involved” workshop.... >>read more

Copyright © 2014 American Psychiatric Association. All rights reserved.

Important information: You are receiving this correspondence because you have previously requested to receive information via email. To unsubscribe to this electronic newsletter, please click here. Please do not reply to this email, as we are unable to respond to messages sent to this address. You can send your comments or questions to PNUpdate@psych.org. The content of Psychiatric News does not necessarily reflect the views of APA or the editors. Unless so stated, neither Psychiatric News nor APA guarantees, warrants, or endorses information or advertising on this site. Clinical information is not peer reviewed and thus should be independently verified. Privacy Policy.